167 related articles for article (PubMed ID: 12521465)
1. Levonorgestrel-releasing intrauterine system for menstrual dysfunction: patient satisfaction in the district general hospital setting.
Macnab JL; Lowles IE
J Obstet Gynaecol; 2002 Jul; 22(4):402-5. PubMed ID: 12521465
[TBL] [Abstract][Full Text] [Related]
2. Levonorgestrel-releasing intrauterine system for treating menstrual disorders: a patient satisfaction questionnaire.
Radesic B; Sharma A
Aust N Z J Obstet Gynaecol; 2004 Jun; 44(3):247-51. PubMed ID: 15191451
[TBL] [Abstract][Full Text] [Related]
3. Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study.
Suhonen S; Haukkamaa M; Jakobsson T; Rauramo I
Contraception; 2004 May; 69(5):407-12. PubMed ID: 15105064
[TBL] [Abstract][Full Text] [Related]
4. Subject and clinician experience with the levonorgestrel-releasing intrauterine system.
Jensen JT; Nelson AL; Costales AC
Contraception; 2008 Jan; 77(1):22-9. PubMed ID: 18082662
[TBL] [Abstract][Full Text] [Related]
5. Selection and performance of the levonorgestrel-releasing intrauterine system.
Lähteenmäki P; Bardin CW; Elomaa K; Haukkamaa M; Kivijärvi A; Kuukankorpi A; Venhola M; Tuominen J
Acta Obstet Gynecol Scand Suppl; 1997; 164():69-74. PubMed ID: 9225643
[TBL] [Abstract][Full Text] [Related]
6. Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts.
Reid PC; Virtanen-Kari S
BJOG; 2005 Aug; 112(8):1121-5. PubMed ID: 16045528
[TBL] [Abstract][Full Text] [Related]
7. A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding.
Busfield RA; Farquhar CM; Sowter MC; Lethaby A; Sprecher M; Yu Y; Sadler LC; Brown P; Johnson N
BJOG; 2006 Mar; 113(3):257-63. PubMed ID: 16487195
[TBL] [Abstract][Full Text] [Related]
8. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
[TBL] [Abstract][Full Text] [Related]
9. Predictors of oligoamenorrhea at 1-year follow-up in premenopausal women using a levonorgestrel-releasing intrauterine system.
de Jonge ET; Yigit R; Molenberghs G; Straetmans D; Ombelet W
Contraception; 2007 Aug; 76(2):91-5. PubMed ID: 17656176
[TBL] [Abstract][Full Text] [Related]
10. Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders.
Lukes AS; Reardon B; Arepally G
Fertil Steril; 2008 Sep; 90(3):673-7. PubMed ID: 18001734
[TBL] [Abstract][Full Text] [Related]
11. The Femilis LNG-IUS: contraceptive performance-an interim analysis.
Wildemeersch D; Janssens D; Andrade A
Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705
[TBL] [Abstract][Full Text] [Related]
12. Levonorgestrel-releasing intrauterine system: why do some women dislike it?
Daud S; Ewies AA
Gynecol Endocrinol; 2008 Dec; 24(12):686-90. PubMed ID: 19172537
[TBL] [Abstract][Full Text] [Related]
13. User satisfaction with a levonorgestrel-releasing intrauterine system (LNG-IUS): data from an international survey.
Römer T; Linsberger D
Eur J Contracept Reprod Health Care; 2009 Dec; 14(6):391-8. PubMed ID: 19929641
[TBL] [Abstract][Full Text] [Related]
14. Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use.
Rönnerdag M; Odlind V
Acta Obstet Gynecol Scand; 1999 Sep; 78(8):716-21. PubMed ID: 10468065
[TBL] [Abstract][Full Text] [Related]
15. Ease of insertion, contraceptive efficacy and safety of new T-shaped levonorgestrel-releasing intrauterine systems.
Wildemeersch D; Janssens D; Vrijens M; Weyers S
Contraception; 2005 Jun; 71(6):465-9. PubMed ID: 15914138
[TBL] [Abstract][Full Text] [Related]
16. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study.
Varma R; Soneja H; Bhatia K; Ganesan R; Rollason T; Clark TJ; Gupta JK
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):169-75. PubMed ID: 18440693
[TBL] [Abstract][Full Text] [Related]
17. Mirena (Levonorgestrel intrauterine system): a successful novel drug delivery option in contraception.
Rose S; Chaudhari A; Peterson CM
Adv Drug Deliv Rev; 2009 Aug; 61(10):808-12. PubMed ID: 19445984
[TBL] [Abstract][Full Text] [Related]
18. Long-term use of the levonorgestrel-releasing intrauterine system.
Inki P
Contraception; 2007 Jun; 75(6 Suppl):S161-6. PubMed ID: 17531611
[TBL] [Abstract][Full Text] [Related]
19. Predictors of bleeding and user satisfaction during consecutive use of the levonorgestrel-releasing intrauterine system.
Heikinheimo O; Inki P; Kunz M; Gemzell-Danielsson K
Hum Reprod; 2010 Jun; 25(6):1423-7. PubMed ID: 20378611
[TBL] [Abstract][Full Text] [Related]
20. The levonorgestrel-releasing intrauterine system as an alternative to hysterectomy in peri-menopausal women.
Milsom I
Contraception; 2007 Jun; 75(6 Suppl):S152-4. PubMed ID: 17531608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]